Journals

JAK inhibitors have expanded options for managing alopecia areata, but questions remain around patient selection, monitoring, and…

Treatment for advanced non-small cell lung cancer (NSCLC) with activating mutations in HER2 relies on chemo-immunotherapy in the…

Data presented at the European Society for Medical Oncology (ESMO) Congress 2025 signal a potential shift in the management of early-stage…

Explore the latest AMJ Rheumatology issue with American College of Rheumatology (ACR) Convergence 2025 highlights including the use of…

This special issue brings you IDWeek 2025 highlights on HIV prevention, infectious disease challenges in correctional settings, and…

Patients with skin of color are under-represented in atopic dermatitis (AD) clinical trials, despite higher incidence and persistence…

The FDA has now approved zongertinib, a tyrosine kinase inhibitor, for the treatment of adult patients with unresectable or metastatic…

BATURA trial results showed that as-needed use of an ICS-SABA combination may help control symptoms and mitigate exacerbation…